Donate Today to Fight Diabetes

Diabetes isn’t a choice, but we can all choose to fight it. Your gift makes a difference and will go a long way to support research for a cure and better treatments as well as to raise awareness about the #EverydayReality of living with this disease. Let’s beat it together! Donate today

Why Give?

Nearly 30 million battle diabetes and every 23 seconds someone new is diagnosed. Diabetes causes more deaths a year than breast cancer and AIDS combined. Your gift today will help us get closer to curing diabetes and better treatments for those living with diabetes.

The American Diabetes Association Announces New Editors for Diabetes Journal

Alexandria, June 17, 2011

The American Diabetes Association announces the appointment of K. Sreekumaran Nair, MD, PhD, Professor of Medicine at the Mayo Clinic and Foundation, as the Editor-in-Chief of Diabetes, the Association’s premier peer-reviewed research journal. Michael D. Jensen, MD, also of the Mayo Clinic and Foundation, and Jeffrey E. Pessin, PhD, of the Albert Einstein College of Medicine, will join Dr. Nair as Senior Associate Editors.

The Association also announced the appointment of the following Associate Editors to the editorial team of Diabetes:

• E. Dale Abel, MD, PhD, of the University of Utah

• Sharon G. Adler, MD, of Harbor-UCLA Medical Center

• Peter J. Dyck, MD, of the Mayo Clinic

• Thomas W. Gardner, MD, MS, of Penn State Hershey Eye Center

• Laurie J. Goodyear, PhD, of Harvard Medical School

• Kathryn M. Haskins, PhD, of the University of Colorado Denver and National Jewish Health

• Gökhan Hotamisligil, MD, PhD, of the Harvard School of Public Health

• Braxton Mitchell, PhD, of the University of Maryland

• Robert A. Rizza, MD, of the Mayo Clinic

• James R. Sowers, MD, of the University of Missouri School of Medicine

• Lori Sussel, PhD, of Columbia University

• Nick Wareham, MD, of Addenbrooke’s Hospital, Cambridge University

The incoming editors will serve a three-year term for the 2012 to 2014 volume years, with an optional two-year extension.

As the incoming Editor-in-Chief of Diabetes, K. Sreekumaran Nair brings more than 30 years of professional and scholarly experience to the journal. Nair is currently professor of medicine and a consultant in the Division of Endocrinology, Diabetes, Nutrition and Metabolism in the Department of Internal Medicine at Mayo Clinic Rochester. He is also the director of the Metabolomics Laboratory of the Mayo Clinic Center for Translational Science Activities, and he is recognized as a Distinguished Investigator at Mayo Clinic and with the distinction of an endowed professorship, the David H. Murdock-Dole Food Company Professorship.

Nair’s research program is supported by National Institutes of Health (NIH) grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute on Aging (NIA), and he started his independent research career with the American Diabetes Association’s Career Development grant. Nair’s research interests include insulin resistance in relation to mitochondrial dysfunction, the impact of age-related muscle changes on insulin resistance, and the impact of altered protein homeostasis and post-translational modifications on diabetic complications. He has served as a reviewer or editorial board member for a number of journals, including Diabetes, American Journal of Clinical Nutrition, Cell Metabolism, Journal of Endocrinology and Metabolism, Journal of Clinical Investigation, Nature Medicine, New England Journal of Medicine, American Journal of Physiology: Endocrinology and Metabolism, Proceedings of the National Academy of Sciences U.S.A., and Science.

Nair and his editorial team will succeed Editor-in-Chief Peter C. Butler, MD, and his current editorial team, which was convened in July 2006 and will complete its term at the end of 2011:

• Mark Atkinson, PhD

• William Cefalu, MD

• Mark E. Cooper, MD, PhD

• Edward W. Kraegen, PhD

• James A. Levine, MD

• Braxton D. Mitchell, Jr., PhD

• Michael Nauck, MD

• Jill M. Norris, MPH, MD

• Jeffrey E. Pessin, PhD (incoming Senior Associate Editor)

• Karen Reue, PhD

• Christopher J. Rhodes, PhD

• Lynne E. Wagenknecht, DrPH

• Karol E. Watson, MD

“It is an honor and a privilege to serve as the Editor-in-Chief of Diabetes,” said Nair, “and my colleagues and I look forward to contributing to its continued success in today’s rapidly changing scientific world.”

Diabetes, the flagship research publication of the American Diabetes Association, is the highest-ranked journal devoted exclusively to diabetes research. Diabetes publishes original research about the physiology and pathophysiology of diabetes and its complications. The journal is published 12 times a year and is received by American Diabetes Association Category I Professional Members.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)